Martin Myers
Marilyn H Vincent Professor of Diabetes Research
Director of the Michigan Diabetes Initiative
Professor of Internal Medicine
Professor of Molecular and Integrative Physiology
Medical School
Internal Medicine
2800 Plymouth Rd., NCRC Bldg 20
Ann Arbor, MI 48109

Available to mentor

Martin Myers
Professor
  • About
  • Qualifications
  • Center Memberships
  • Research Overview
  • Recent Publications
  • Manage Your Profile
    About

    Dr. Myers received his undergraduate degree in Molecular Biology (summa cum laude) at Princeton University in 1988 and his M.D. and Ph.D. (Cell Biology) degrees from Harvard Medical School in 1997. He joined the faculty at the Joslin Diabetes Center at Harvard Medical School in 1997, where he began to focus his independent research laboratory on mechanisms of leptin receptor signaling and links to the regulation of mammalian physiology. In 2004, Dr. Myers moved to the University of Michigan as a Michigan Biomedical Sciences Scholar and joined the faculty of Internal Medicine and Molecular and Integrative Physiology. Dr. Myers is the Director of the Elizabeth Weiser Caswell Diabetes Institute and the Michigan Diabetes Research Center.

    Dr. Myers has been recognized with numerous awards and accolades. He received the Michigan Biomedical Sciences Scholar Award in 2004, was elected to the ASCI in 2005, received the Jerome Conn Award for Excellence in Research in 2006, and the American Diabetes Association’s Outstanding Scientific Achievement Award in 2010.

    Qualifications
    • Postdoctoral Fellow
      Harvard Medical School/Joslin Diabetes Center, Boston, 1997
    • MD
      Harvard University, 1997
    • PhD
      Harvard University, 1997
    • AB
      Princeton University, 1988
    Center Memberships
    • Center Member
      Caswell Diabetes Institute
    Research Overview

    Dr. Myers’ research focuses on how the central nervous system controls processes that enable the body to control blood glucose and body weight, and how problems in these pathways contribute to the development of insulin resistance and diabetes. His laboratory focuses on the crucial roles played by nerve centers in the unconscious part of the brain — including regions that control food intake and metabolism to regulate body weight, and “glycemic control centers” that regulate the body’s ability to control blood sugar.

    Recent Publications See All Publications
    • Journal Article
      Author Correction: Paraventricular, subparaventricular and periventricular hypothalamic IRS4-expressing neurons are required for normal energy balance (Scientific Reports, (2020), 10, 1, (5546), 10.1038/s41598-020-62468-z)
      Sutton Hickey AK, Gonzalez IE, Sadagurski M, Rajala M, Lu C, Allison MB, Adams JM, Myers MG, White MF, Olson DP. Scientific Reports, 2025 Dec 1; 15 (1): DOI:10.1038/s41598-025-85804-7
      PMID: 39966516
    • Journal Article
      Roles for Prlhr/GPR10 and Npffr2/GPR74 in feeding responses to PrRP
      Wang Y, Qiu W, Kernodle S, Parker C, Padilla MA, Su J, Tomlinson AJ, Oldham S, Field J, Bernard E, Hornigold D, Rhodes CJ, Olson DP, Seeley RJ, Myers MG. Molecular Metabolism, 2025 Feb 1; 92: DOI:10.1016/j.molmet.2024.102093
      PMID: 39755369
    • Preprint
      A single dorsal vagal complex circuit mediates the aversive and anorectic responses to GLP1R agonists.
      Yacawych WT, Wang Y, Zhou G, Hassan S, Kernodle S, Sass F, DeVaux M, Wu I, Rupp A, Tomlinson AJ, Lin Z, Secher A, Raun K, Pers T, Seeley RJ, Myers M, Qiu W. 2025 Jan 24; DOI:10.1101/2025.01.21.634167
      PMID: 39896596
    • Journal Article
      A Cross-Species Atlas of the Dorsal Vagal Complex Reveals Neural Mediators of Cagrilintide's Effects on Energy Balance.
      Ludwig MQ, Coester B, Gordian D, Hassan S, Tomlinson AJ, Toure MH, Christensen OP, Moltke-Prehn A, Brown JM, Rausch DM, Gowda A, Wu I, Kernodle S, Dong V, Ayensu-Mensah M, Sabatini PV, Shin JH, Kirigiti M, Egerod KL, Le Foll C, Lundh S, Gerstenberg MK, Lutz TA, Kievit P, Secher A, Raun K, Myers MG, Pers TH. bioRxiv, 2025 Jan 15; DOI:10.1101/2025.01.13.632726
      PMID: PMC11760743
    • Journal Article
      Glp1r-Lepr coexpressing neurons modulate the suppression of food intake and body weight by a GLP-1/leptin dual agonist
      Polex-Wolf J, Deibler K, Hogendorf WFJ, Bau S, Glendorf T, Stidsen CE, Tornøe CW, Tiantang D, Lundh S, Pyke C, Tomlinson AJ, Kernodle S, Magrisso IJ, Conde-Frieboes KW, Myers MG, Knudsen LB, Seeley RJ. Science Translational Medicine, 2024 Dec 4; 16 (776): DOI:10.1126/scitranslmed.adk4908
      PMID: 39630884
    • Journal Article
      NK2R control of energy expenditure and feeding to treat metabolic diseases
      Sass F, Ma T, Ekberg JH, Kirigiti M, Ureña MG, Dollet L, Brown JM, Basse AL, Yacawych WT, Burm HB, Andersen MK, Nielsen TS, Tomlinson AJ, Dmytiyeva O, Christensen DP, Bader L, Vo CT, Wang Y, Rausch DM, Kristensen CK, Gestal-Mato M, In het Panhuis W, Sjøberg KA, Kernodle S, Petersen JE, Pavlovskyi A, Sandhu M, Moltke I, Jørgensen ME, Albrechtsen A, Grarup N, Babu MM, Rensen PCN, Kooijman S, Seeley RJ, Worthmann A, Heeren J, Pers TH, Hansen T, Gustafsson MBF, Tang-Christensen M, Kilpeläinen TO, Myers MG, Kievit P, Schwartz TW, Hansen JB, Gerhart-Hines Z. Nature, 2024 Nov 28; 635 (8040): 987 - 1000. DOI:10.1038/s41586-024-08207-0
      PMID: 39537932
    • Preprint
      Glutamate neurotransmission from leptin receptor cells is required for typical puberty and reproductive function in female mice
      Sáenz de Miera C, Bellefontaine N, Allen SJ, Myers MG, Elias CF. 2024 Jul 15; DOI:10.7554/eLife.93204
    • Journal Article
      Glutamate neurotransmission from leptin receptor cells is required for typical puberty and reproductive function in female mice
      Sáenz de Miera C, Bellefontaine N, Allen SJ, Myers MG, Elias CF. eLife, 2024 Jun 24; DOI:10.7554/eLife.93204
    Featured News & Stories 2025 Dean's Lecture and Bold Science Symposium
    Medical School News
    2025 Dean’s Lecturer: GLP-1 therapies saving, improving lives of many patients
    Lives are being saved, and many others are being changed dramatically, by current GLP-1 therapies like tirzepatide, which has helped many patients treat type 2 diabetes and sleep apnea, and also lose weight. It has been a long road from bench research to clinical trials to the health care market, but patients are now benefitting more than ever, according to a leading scientist who served as the keynote speaker for the second annual Dean’s Lecture and Bold Science Symposium, “Metabolism Research from Bench to Bedside.” Daniel Skovronsky, M.D., Ph.D., chief scientific officer and executive vice president of science and technology at Eli Lilly and Company and president of Research Laboratories and Lilly Immunology, was the Dean’s Lecturer on April 14 at the North Campus Research Complex Dining Hall.